Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abed Rahman Kawakibi

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Journal of Surgical Research|November 4, 2021
Perceived Barriers to the De-implementation of Routine Preoperative History & Physicals Preceding Low-Risk Ambulatory Procedures: A Qualitative Study of Surgeon PerspectivesAlison S Baskin, Alexandra I Mansour, Abed Rahman Kawakibi, et al.
Current Oncology Reports|April 17, 2020
Correction to: Targeting and Therapeutic Monitoring of H3K27M-Mutant GliomaKyle Wierzbicki, Karthik Ravi, Andrea Franson, et al.
Current Oncology Reports|February 8, 2020
Targeting and Therapeutic Monitoring of H3K27M-Mutant GliomaKyle Wierzbicki, Karthik Ravi, Andrea Franson, et al.
Neoplasia (New York, N.Y.)|November 3, 2020
ONC201 and imipridones: Anti-cancer compounds with clinical efficacyVarun Vijay Prabhu, Sara Morrow, Abed Rahman Kawakibi, et al.
Neuro-Oncology|February 9, 2022
Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline gliomaEvan Cantor, Kyle Wierzbicki, Rohinton S Tarapore, et al.
Cancer Discovery|August 16, 2023
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic PathwaysSriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Journal of Surgical Research|November 4, 2021
Perceived Barriers to the De-implementation of Routine Preoperative History & Physicals Preceding Low-Risk Ambulatory Procedures: A Qualitative Study of Surgeon PerspectivesAlison S Baskin, Alexandra I Mansour, Abed Rahman Kawakibi, et al.
Current Oncology Reports|April 17, 2020
Correction to: Targeting and Therapeutic Monitoring of H3K27M-Mutant GliomaKyle Wierzbicki, Karthik Ravi, Andrea Franson, et al.
Current Oncology Reports|February 8, 2020
Targeting and Therapeutic Monitoring of H3K27M-Mutant GliomaKyle Wierzbicki, Karthik Ravi, Andrea Franson, et al.
Neoplasia (New York, N.Y.)|November 3, 2020
ONC201 and imipridones: Anti-cancer compounds with clinical efficacyVarun Vijay Prabhu, Sara Morrow, Abed Rahman Kawakibi, et al.
Neuro-Oncology|February 9, 2022
Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline gliomaEvan Cantor, Kyle Wierzbicki, Rohinton S Tarapore, et al.
Cancer Discovery|August 16, 2023
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic PathwaysSriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, et al.
Pageof 1